365 related articles for article (PubMed ID: 37228649)
1. H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets.
Burlibasa L; Nicu AT; Chifiriuc MC; Medar C; Petrescu A; Jinga V; Stoica I
Front Cell Dev Biol; 2023; 11():1181764. PubMed ID: 37228649
[TBL] [Abstract][Full Text] [Related]
2. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
[TBL] [Abstract][Full Text] [Related]
3. Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer.
Li Y; Guo D; Sun R; Chen P; Qian Q; Fan H
Dig Dis Sci; 2019 Feb; 64(2):439-446. PubMed ID: 30350241
[TBL] [Abstract][Full Text] [Related]
4. Traffic-derived particulate matter exposure and histone H3 modification: A repeated measures study.
Zheng Y; Sanchez-Guerra M; Zhang Z; Joyce BT; Zhong J; Kresovich JK; Liu L; Zhang W; Gao T; Chang D; Osorio-Yanez C; Carmona JJ; Wang S; McCracken JP; Zhang X; Chervona Y; Díaz A; Bertazzi PA; Koutrakis P; Kang CM; Schwartz J; Baccarelli AA; Hou L
Environ Res; 2017 Feb; 153():112-119. PubMed ID: 27918982
[TBL] [Abstract][Full Text] [Related]
5. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
6. Advances in Epigenetic Cancer Therapeutics.
Hillyar C; Rallis KS; Varghese J
Cureus; 2020 Nov; 12(11):e11725. PubMed ID: 33391954
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Histone H3 Lysine 4 and 36 Tri-methylation in
Mehraj H; Takahashi S; Miyaji N; Akter A; Suzuki Y; Seki M; Dennis ES; Fujimoto R
Front Plant Sci; 2021; 12():659634. PubMed ID: 34163501
[TBL] [Abstract][Full Text] [Related]
8. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
Sahafnejad Z; Ramazi S; Allahverdi A
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
[TBL] [Abstract][Full Text] [Related]
9. Methylation patterns of Lys9 and Lys27 on histone H3 correlate with patient outcome and tumor progression in lung cancer.
Zhang Y; Zheng B; Lou K; Xu X; Xu Y
Ann Diagn Pathol; 2022 Dec; 61():152045. PubMed ID: 36115104
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics in bladder cancer.
Enokida H; Nakagawa M
Int J Clin Oncol; 2008 Aug; 13(4):298-307. PubMed ID: 18704629
[TBL] [Abstract][Full Text] [Related]
11. Identification of key genes and important histone modifications in hepatocellular carcinoma.
Liu YX; Li QZ; Cao YN; Zhang LQ
Comput Struct Biotechnol J; 2020; 18():2657-2669. PubMed ID: 33033585
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive characterization of the epigenetic landscape in Multiple Myeloma.
Alaterre E; Ovejero S; Herviou L; de Boussac H; Papadopoulos G; Kulis M; Boireau S; Robert N; Requirand G; Bruyer A; Cartron G; Vincent L; Martinez AM; Martin-Subero JI; Cavalli G; Moreaux J
Theranostics; 2022; 12(4):1715-1729. PubMed ID: 35198065
[No Abstract] [Full Text] [Related]
13. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
Godino A; Jayanthi S; Cadet JL
Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1α cooperates with histone Lys methylation to predict prognosis in esophageal squamous cell carcinoma.
Shen X; Li Y; Xu Y; Liu M; Zhang Q; Yin R; Zhou M; Lin S; Fan H
Biomark Med; 2021 May; 15(7):509-522. PubMed ID: 33856264
[No Abstract] [Full Text] [Related]
15. Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.
Ke XS; Qu Y; Rostad K; Li WC; Lin B; Halvorsen OJ; Haukaas SA; Jonassen I; Petersen K; Goldfinger N; Rotter V; Akslen LA; Oyan AM; Kalland KH
PLoS One; 2009; 4(3):e4687. PubMed ID: 19262738
[TBL] [Abstract][Full Text] [Related]
16. Effect of titanium dioxide nanoparticles on histone modifications and histone modifying enzymes expression in human cell lines.
Pogribna M; Word B; Lyn-Cook B; Hammons G
Nanotoxicology; 2022 May; 16(4):409-424. PubMed ID: 35876074
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of prostate cancer: the theories and the clinical implications.
Liao Y; Xu K
Asian J Androl; 2019; 21(3):279-290. PubMed ID: 30084432
[TBL] [Abstract][Full Text] [Related]
18. Role of histone methylation in skin cancers: Histone methylation-modifying enzymes as a new class of targets for skin cancer treatment.
Sutopo NC; Kim JH; Cho JY
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188865. PubMed ID: 36841366
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
[TBL] [Abstract][Full Text] [Related]
20. Hypo-trimethylation of Histone H3 Lysine 4 and Hyper-tri/dimethylation of Histone H3 Lysine 27 as Epigenetic Markers of Poor Prognosis in Patients with Primary Central Nervous System Lymphoma.
Kim HG; Kim MS; Lee YS; Lee EH; Kim DC; Lee SH; Kim YZ
Cancer Res Treat; 2022 Jul; 54(3):690-708. PubMed ID: 34793663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
